Observational clinical study of 22 adult-onset Pompe disease patients undergoing enzyme replacement therapy over 5years
Karolina M. Stępień(Medical University of Warsaw), Reena Sharma(Salford Royal NHS Foundation Trust), Christian J. Hendriksz(Birmingham Children's Hospital), Mark Roberts(Sherwood Forest Hospitals NHS Foundation Trust)
Cited by 52
Related Papers
Recommendations for the diagnosis and management of Niemann–Pick disease type C: An update
|Molecular Genetics and Metabolism|2012|478
Recommendations for initiation and cessation of enzyme replacement therapy in patients with Fabry disease: the European Fabry Working Group consensus document
|Orphanet Journal of Rare Diseases|2015|345
British Thoracic Society Guideline for pleural disease
|Thorax|2023|287
Efficacy and safety of enzyme replacement therapy with BMN 110 (elosulfase alfa) for Morquio A syndrome (mucopolysaccharidosis IVA): a phase 3 randomised placebo‐controlled study
|Journal of Inherited Metabolic Disease|2014|211